1. Home
  2. REFR vs TELA Comparison

REFR vs TELA Comparison

Compare REFR & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$0.97

Market Cap

33.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.66

Market Cap

37.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REFR
TELA
Founded
1965
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.6M
37.5M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
REFR
TELA
Price
$0.97
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.00
AVG Volume (30 Days)
26.0K
173.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.59
EPS
N/A
N/A
Revenue
$1,488,642.00
$80,275,000.00
Revenue This Year
N/A
$10.23
Revenue Next Year
N/A
$14.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.84
52 Week Low
$0.82
$0.50
52 Week High
$2.70
$2.19

Technical Indicators

Market Signals
Indicator
REFR
TELA
Relative Strength Index (RSI) 48.36 44.95
Support Level $0.90 N/A
Resistance Level $1.04 $1.24
Average True Range (ATR) 0.06 0.13
MACD 0.01 -0.00
Stochastic Oscillator 61.90 40.69

Price Performance

Historical Comparison
REFR
TELA

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: